Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ DLST Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5109638
Description
Immunogen sequence: PAKAKPAEAP AAAAPKAEPT AAAVPPPAAP IPTQMPPVPS PSQPPSGKPV SAVKPTVAPP LAEPGAGKGL RSEHREKMNR MRQRIAQRLK EAQNTCAMLT T.
This gene encodes a mitochondrial protein that belongs to the 2-oxoacid dehydrogenase family. This protein is one of the three components (the E2 component) of the 2-oxoglutarate dehydrogenase complex that catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO(2). Alternatively spliced transcript variants have been found for this gene.
Specifications
| DLST | |
| Polyclonal | |
| Unconjugated | |
| Dlst | |
| 1600017E01Rik; 2-oxoglutarate dehydrogenase complex component E2; 4632413C10Rik; 4930529O08Rik; dihydrolipoamide S-succinyltransferase; dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex); dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex; Dihydrolipoyllysine-residue succinyltransferase; dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial; DLST; DLTS; E2; E2K; OGDC-E2 | |
| Rabbit | |
| Affinity Chromatography | |
| RUO | |
| 1743, 299201, 78920 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 1.77 mg/mL | |
| PBS with 50% glycerol and 0.09% sodium azide; pH 7.3 | |
| P36957, Q01205, Q9D2G2 | |
| Dlst | |
| A synthetic peptide corresponding to a sequence within amino acids 150-250 of human DLST (NP_001924.2). | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction